​

UnitedHealth Group (UNH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

UNH Stock Forecast

UnitedHealth Group stock forecast is as follows: an average price target of $625.00 (represents a 16.15% upside from UNH’s last price of $538.10) and a rating consensus of 'Buy', based on 32 wall street analysts offering a 1-year stock forecast.

UNH Price Target

The average price target for UnitedHealth Group (UNH) is $625.00 based on 1-year price targets from 32 Wall Street analysts in the past 3 months, with a price target range of $650.00 to $595.00. This represents a potential 16.15% upside from UNH's last price of $538.10.

UNH Analyst Ratings

Buy

According to 32 Wall Street analysts, UnitedHealth Group's rating consensus is 'Buy'. The analyst rating breakdown for UNH stock is 1 'Strong Buy' (3.13%), 26 'Buy' (81.25%), 3 'Hold' (9.38%), 2 'Sell' (6.25%), and 0 'Strong Sell' (0.00%).

UnitedHealth Group Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 09, 2024David WindleyJefferies$635.00$549.5315.55%18.01%
Oct 16, 2024Ben HendrixRBC Capital$595.00$556.296.96%10.57%
Oct 16, 2024David MacDonaldTruist Financial$625.00$556.2912.35%16.15%
Oct 16, 2024Joanna GajukBank of America Securities$650.00$556.2916.85%20.80%
Oct 16, 2024David WindleyJefferies$643.00$556.2915.59%19.49%
Oct 16, 2024George HillDeutsche Bank$595.00$556.296.96%10.57%
Oct 16, 2024Matthew GillmorKeyBanc$650.00$569.6614.10%20.80%
Oct 10, 2024Matthew GillmorKeyBanc$675.00$597.7012.93%25.44%
Jul 17, 2024David ToungArgus Research$600.00$565.786.05%11.50%
Jul 17, 2024David MacDonaldTruist Financial$640.00$548.8716.60%18.94%
Jul 17, 2024Scott FidelStephens$600.00$548.879.32%11.50%
Jul 17, 2024David WindleyJefferies$647.00$573.2812.86%20.24%
Jun 05, 2024Sidharth SahooHSBC$580.00$503.1215.28%7.79%
Apr 19, 2024George HillDeutsche Bank$562.00$493.1813.95%4.44%
Apr 17, 2024Stephen BaxterWells Fargo$525.00$483.158.66%-2.43%
Apr 17, 2024Ben HendrixRBC Capital$555.00$468.8918.36%3.14%
Apr 17, 2024Jessica TassanPiper Sandler$571.00$468.8921.78%6.11%
Apr 11, 2024Jessica TassanPiper Sandler$566.00$450.0525.76%5.18%
Apr 05, 2024Erin WrightMorgan Stanley$584.00$455.3828.24%8.53%
Apr 04, 2024Rajesh KumarHSBC$460.00$454.651.18%-14.51%
Jul 17, 2023Michael WiederhornOppenheimer$610.00$483.4626.17%13.36%
Apr 05, 2023Strong BuyRaymond James$630.00$510.8623.32%17.08%
Dec 07, 2022Credit Suisse$610.00$542.4812.45%13.36%
Nov 23, 2022Morgan Stanley$587.00$525.1811.77%9.09%
Sep 22, 2022Raymond James$635.00$512.0824.00%18.01%
Sep 08, 2022Deutsche Bank$569.00$525.088.36%5.74%
Aug 10, 2022Mizuho Securities$600.00$537.4311.64%11.50%
Aug 03, 2022Kavin CaliendoUBS$570.00$542.525.06%5.93%
Jul 25, 2022Argus Research$650.00$528.4922.99%20.80%
Jul 19, 2022Deutsche Bank$556.00$528.985.11%3.33%
Jul 18, 2022Leerink Partners$625.00$525.3018.98%16.15%
Jul 18, 2022Credit Suisse$579.00$525.8710.10%7.60%
May 31, 2022Stephen BaxterWells Fargo$612.00$507.1120.68%13.73%
Apr 25, 2022Matt BorschBMO Capital$600.00$517.5715.93%11.50%
Apr 22, 2022Wells Fargo$613.00$537.4414.06%13.92%
Apr 20, 2022Ben HendrixRBC Capital$588.00$537.709.35%9.27%
Apr 14, 2022Ann HynesMizuho Securities$550.00$534.822.84%2.21%
Apr 13, 2022Kevin CaliendoUBS$545.00$537.001.49%1.28%
Apr 07, 2022David S MacdonaldTruist Financial$610.00$536.9513.60%13.36%
Apr 06, 2022David WindleyJefferies$485.00$531.75-8.79%-9.87%
Apr 03, 2022Steve ValiquetteBarclays$565.00$512.5910.22%5.00%
Jan 30, 2022Whit MayoLeerink Partners$550.00$466.0618.01%2.21%
Jan 20, 2022Kevin CaliendoUBS$468.00$461.631.38%-13.03%
Jan 19, 2022Kevin FischbeckBank of America Securities$574.20$461.1624.51%6.71%
Jan 19, 2022Michael NewshelEvercore ISI$480.00$461.164.09%-10.80%
Jan 19, 2022Ben HendrixRBC Capital$563.00$461.1622.08%4.63%
Jan 14, 2022Joseph FranceSeaport Global$525.00$467.3112.35%-2.43%
Jan 11, 2022Lance WilkesBernstein$564.00$467.6220.61%4.81%
Dec 17, 2021Lisa GillJ.P. Morgan$540.00$485.6811.18%0.35%
Dec 14, 2021Nathan RichGoldman Sachs$535.00$478.0411.92%-0.58%
Dec 01, 2021Scott FidelStephens$475.00$441.597.57%-11.73%
Dec 01, 2021Ricky GoldwasserMorgan Stanley$526.00$441.5919.12%-2.25%
Oct 15, 2021A.J. RiceCredit Suisse$495.00$425.4216.36%-8.01%
Oct 15, 2021Michael WiederhornOppenheimer$475.00$425.4211.65%-11.73%
Oct 14, 2021Steven HalperCantor Fitzgerald$465.00$417.7611.31%-13.58%
Apr 26, 2021Justin LakeWolfe Research$442.00$390.6013.16%-17.86%
Apr 21, 2021David ToungArgus Research$450.00$393.5114.36%-16.37%

The latest UnitedHealth Group stock forecast, released on Dec 09, 2024 by David Windley from Jefferies, set a price target of $635.00, which represents a 15.55% increase from the stock price at the time of the forecast ($549.53), and a 18.01% increase from UNH last price ($538.10).

UnitedHealth Group Price Target by Period

1M3M12M
# Anlaysts-120
Avg Price Target-$635.00$597.90
Last Closing Price$538.10$538.10$538.10
Upside/Downside-100.00%18.01%11.11%

In the current month, the average price target of UnitedHealth Group stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to UnitedHealth Group's last price of $538.10. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Dec 09, 2024JefferiesBuyBuyHold
Dec 05, 2024StephensOverweightOverweightHold
Oct 22, 2024UBSBuyBuyHold
Oct 17, 2024HSBCBuyHoldDowngrade
Oct 16, 2024Cantor FitzgeraldOverweightOverweightHold
Oct 16, 2024RBC CapitalOutperformOutperformHold
Oct 16, 2024StephensOverweightOverweightHold
Oct 16, 2024JefferiesBuyBuyHold
Oct 16, 2024Deutsche BankBuyBuyHold
Oct 16, 2024KeyBancOverweightOverweightHold
Oct 11, 2024Wells FargoBuyBuyHold
Oct 11, 2024Cowen & Co.BuyBuyHold
Oct 10, 2024KeyBancOverweightInitialise
Sep 10, 2024UBSUnderperformUnderperformHold
Sep 10, 2024Wells FargoBuyBuyHold
Aug 19, 2024Wells FargoBuyBuyHold
Jul 17, 2024RBC CapitalUnderperformUnderperformHold
Jul 17, 2024Wells FargoBuyBuyHold
Jul 17, 2024RBC CapitalOutperformOutperformHold
Jul 17, 2024Cowen & Co.BuyBuyHold
Jul 17, 2024Morgan StanleyOverweightOverweightHold
Jul 17, 2024Wells FargoOverweightOverweightHold
Jul 17, 2024StephensOverweightOverweightHold
Jul 17, 2024JefferiesBuyUpgrade
Jul 17, 2024BarclaysOverweightOverweightHold
Jul 14, 2024BernsteinOutperformOutperformHold
Jun 24, 2024Morgan StanleyOverweightOverweightHold
Jun 05, 2024HSBCHoldBuyUpgrade
May 30, 2024RBC CapitalUnderperformUnderperformHold
May 30, 2024Wells FargoBuyBuyHold
May 30, 2024Piper SandlerOverweightOverweightHold
Apr 19, 2024Deutsche BankBuyBuyHold
Apr 17, 2024Wells FargoEqual-WeightEqual-WeightHold
Apr 17, 2024RBC CapitalOutperformOutperformHold
Apr 17, 2024Piper SandlerOverweightOverweightHold
Apr 17, 2024BarclaysOverweightOverweightHold
Apr 16, 2024Goldman SachsBuyBuyHold
Apr 05, 2024Morgan StanleyOverweightOverweightHold
Apr 04, 2024RBC CapitalUnderperformUnderperformHold
Apr 04, 2024StephensBuyBuyHold
Apr 04, 2024HSBCHoldUpgrade
Feb 29, 2024StephensOutperformOutperformHold
Feb 29, 2024RBC CapitalUnderperformUnderperformHold
Jan 16, 2024RBC CapitalUnderperformUnderperformHold
Jan 16, 2024StephensBuyBuyHold
Oct 16, 2023UBSNeutralBuyUpgrade
Jul 18, 2023BenchmarkSpeculative BuyInitialise
Jul 18, 2023SusquehannaPositiveInitialise
Jul 18, 2023William BlairOutperformInitialise
Jul 18, 2023BTIGBuyInitialise
Jul 18, 2023Piper SandlerOverweightInitialise
Jul 18, 2023B. Riley SecuritiesBuyInitialise
Jul 18, 2023BarclaysOverweightEqual-WeightInitialise
Jul 18, 2023Redburn PartnersSellInitialise
Jul 18, 2023MacquarieOutperformInitialise
Jul 18, 2023GuggenheimBuyInitialise
Jul 18, 2023BernsteinMarket PerformOutperformUpgrade
Jul 17, 2023OppenheimerOutperformOutperformHold
Apr 17, 2023Loop Capital MarketsBuyBuyHold
Dec 07, 2022Credit SuisseOutperformOutperformHold
Oct 17, 2022MKM PartnersBuyBuyHold
Sep 22, 2022Raymond JamesStrong BuyStrong BuyHold
Sep 08, 2022Deutsche BankBuyBuyHold
Aug 22, 2022NeedhamHoldDowngrade
Aug 22, 2022CFRASellDowngrade
Aug 22, 2022RBC CapitalOutperformUnderperformDowngrade
Jul 25, 2022Argus ResearchBuyBuyHold
Jul 21, 2022UBSNeutralNeutralHold
Jul 19, 2022Deutsche BankBuyBuyHold
Jul 18, 2022OppenheimerOutperformOutperformHold
Jul 18, 2022SVB LeerinkOutperformOutperformHold
Jul 18, 2022Credit SuisseOutperformOutperformHold
May 25, 2022Wells FargoOverweightOverweightHold
Apr 25, 2022BMO CapitalMarket PerformMarket PerformHold
Apr 23, 2022Cowen & Co.OutperformOutperformHold
Apr 20, 2022RBC CapitalOutperformOutperformHold
Apr 03, 2022BarclaysOverweightOverweightHold
Feb 06, 2022SVB LeerinkOutperformOutperformHold
Jan 14, 2022BernsteinOutperformOutperformHold
Dec 02, 2021BMO CapitalNeutralNeutralHold
Jan 18, 2021BarclaysBuyBuyHold

UnitedHealth Group's last stock rating was published by Jefferies on Dec 09, 2024. The company gave UNH a "Buy" rating, the same as its previous rate.

UnitedHealth Group Financial Forecast

UnitedHealth Group Revenue Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Revenue-----------------$92.36B$91.79B$91.13B$81.93B$80.38B$80.04B$79.78B$72.93B$71.83B$70.77B$69.74B$65.02B$64.76B
Avg Forecast$129.04B$129.33B$127.90B$126.13B$122.71B$121.98B$121.02B$120.12B$114.54B$113.63B$112.16B$111.24B$101.60B$99.14B$98.79B$99.22B$92.13B$91.41B$90.97B$89.71B$82.48B$80.52B$79.68B$78.73B$72.98B$71.38B$69.51B$69.07B$64.96B$63.79B
High Forecast$131.21B$131.50B$130.05B$128.25B$124.77B$124.03B$123.06B$122.14B$116.46B$115.54B$114.05B$112.73B$103.47B$99.19B$98.79B$99.23B$93.44B$92.95B$92.50B$91.22B$85.48B$82.32B$81.45B$80.48B$74.61B$72.97B$71.05B$70.61B$66.41B$65.21B
Low Forecast$125.80B$126.08B$124.69B$122.97B$119.63B$118.92B$117.99B$117.10B$111.66B$110.78B$109.35B$108.04B$100.65B$99.09B$98.79B$99.21B$90.78B$89.12B$88.69B$87.46B$80.59B$78.98B$78.15B$77.22B$71.58B$70.01B$68.17B$67.75B$63.72B$62.57B
# Analysts6666666651091313866121010115555666678
Surprise %-----------------1.01%1.01%1.02%0.99%1.00%1.00%1.01%1.00%1.01%1.02%1.01%1.00%1.02%

UnitedHealth Group's average Quarter revenue forecast for Dec 23 based on 12 analysts is $92.13B, with a low forecast of $90.78B, and a high forecast of $93.44B. UNH's average Quarter revenue forecast represents a -0.25% decrease compared to the company's last Quarter revenue of $92.36B (Sep 23).

UnitedHealth Group EBITDA Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts6666666651091313866121010115555666678
EBITDA-----------------$9.53B$7.96B$8.26B$7.02B$7.78B$7.64B$7.37B$6.19B$6.40B$6.65B$7.38B$4.11B$5.29B
Avg Forecast$12.22B$12.25B$12.12B$11.95B$11.62B$11.56B$11.47B$11.38B$10.85B$10.76B$10.63B$10.54B$9.62B$9.39B$9.36B$9.03B$8.73B$8.66B$8.62B$8.21B$6.53B$7.29B$7.21B$7.46B$6.61B$6.46B$6.29B$5.81B$5.88B$5.77B
High Forecast$12.43B$12.46B$12.32B$12.15B$11.82B$11.75B$11.66B$11.57B$11.03B$10.95B$10.80B$10.68B$9.80B$9.40B$9.36B$10.83B$8.85B$8.81B$8.76B$9.85B$7.83B$7.45B$7.37B$8.95B$6.75B$6.61B$6.43B$6.98B$6.01B$5.90B
Low Forecast$11.92B$11.94B$11.81B$11.65B$11.33B$11.27B$11.18B$11.09B$10.58B$10.49B$10.36B$10.24B$9.54B$9.39B$9.36B$7.22B$8.60B$8.44B$8.40B$6.57B$5.22B$7.15B$7.07B$5.97B$6.48B$6.34B$6.17B$4.65B$5.77B$5.66B
Surprise %-----------------1.10%0.92%1.01%1.08%1.07%1.06%0.99%0.94%0.99%1.06%1.27%0.70%0.92%

12 analysts predict UNH's average Quarter EBITDA for Dec 23 to be $8.73B, with a high of $8.85B and a low of $8.60B. This is -8.45% lower than UnitedHealth Group's previous annual EBITDA (Sep 23) of $9.53B.

UnitedHealth Group Net Income Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts6666666651091313866121010115555666678
Net Income-----------------$5.84B$5.47B$5.61B$4.76B$5.26B$5.07B$5.03B$4.19B$4.09B$4.27B$4.86B$2.21B$3.17B
Avg Forecast$7.94B$8.86B$8.83B$8.75B$7.56B$7.93B$7.77B$7.77B$6.78B$7.07B$6.92B$6.77B$6.25B$6.49B$6.16B$5.96B$5.55B$5.87B$5.55B$5.42B$4.29B$5.05B$4.84B$4.92B$4.00B$4.11B$4.12B$3.83B$2.24B$2.89B
High Forecast$8.11B$9.05B$9.02B$8.94B$7.72B$8.11B$7.94B$7.94B$6.93B$7.23B$7.08B$7.41B$6.43B$6.52B$6.16B$7.15B$5.58B$6.00B$5.67B$6.50B$5.15B$5.20B$4.98B$5.91B$4.12B$4.23B$4.24B$4.60B$2.30B$2.97B
Low Forecast$7.68B$8.57B$8.54B$8.46B$7.31B$7.67B$7.52B$7.51B$6.56B$6.84B$6.70B$5.52B$5.98B$6.46B$6.16B$4.77B$5.47B$5.68B$5.37B$4.33B$3.43B$4.92B$4.72B$3.94B$3.90B$4.00B$4.02B$3.06B$2.18B$2.82B
Surprise %-----------------0.99%0.99%1.04%1.11%1.04%1.05%1.02%1.05%1.00%1.03%1.27%0.99%1.10%

UnitedHealth Group's average Quarter net income forecast for Dec 23 is $5.55B, with a range of $5.47B to $5.58B. UNH's average Quarter net income forecast represents a -5.02% decrease compared to the company's last Quarter net income of $5.84B (Sep 23).

UnitedHealth Group SG&A Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts6666666651091313866121010115555666678
SG&A------------------------------
Avg Forecast$3.84B$3.84B$3.80B$3.75B$3.65B$3.63B$3.60B$3.57B$3.40B$3.38B$3.33B$3.31B$3.02B$2.95B$2.94B$2.95B$2.74B$2.72B$2.70B$2.67B$2.45B$12.15B$12.03B$11.88B$11.02B$10.77B$10.49B$10.43B$9.81B$9.63B
High Forecast$3.90B$3.91B$3.87B$3.81B$3.71B$3.69B$3.66B$3.63B$3.46B$3.43B$3.39B$3.35B$3.08B$2.95B$2.94B$2.95B$2.78B$2.76B$2.75B$2.71B$2.54B$12.42B$12.29B$12.15B$11.26B$11.01B$10.72B$10.66B$10.02B$9.84B
Low Forecast$3.74B$3.75B$3.71B$3.66B$3.56B$3.54B$3.51B$3.48B$3.32B$3.29B$3.25B$3.21B$2.99B$2.95B$2.94B$2.95B$2.70B$2.65B$2.64B$2.60B$2.40B$11.92B$11.80B$11.66B$10.80B$10.57B$10.29B$10.23B$9.62B$9.44B
Surprise %------------------------------

UnitedHealth Group's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to UNH last annual SG&A of $NaN (undefined).

UnitedHealth Group EPS Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts6666666651091313866121010115555666678
EPS-----------------$6.31$5.88$6.01$5.10$5.63$5.41$5.34$4.45$4.34$4.52$5.15$2.34$3.34
Avg Forecast$8.56$9.56$9.52$9.44$8.15$8.56$8.38$8.38$7.31$7.63$7.47$7.30$6.74$7.01$6.65$6.61$5.98$6.33$5.99$6.16$5.17$5.43$5.21$5.37$4.31$4.42$4.43$4.39$2.41$3.11
High Forecast$8.75$9.77$9.73$9.64$8.33$8.74$8.56$8.56$7.47$7.80$7.63$8.00$6.94$7.04$6.65$6.61$6.02$6.47$6.12$6.30$5.42$5.59$5.36$5.53$4.43$4.54$4.56$4.52$2.48$3.20
Low Forecast$8.28$9.24$9.21$9.13$7.88$8.28$8.11$8.10$7.07$7.38$7.23$5.96$6.45$6.97$6.65$6.60$5.90$6.13$5.80$5.96$5.02$5.29$5.08$5.24$4.20$4.31$4.32$4.28$2.35$3.03
Surprise %-----------------1.00%0.98%0.98%0.99%1.04%1.04%0.99%1.03%0.98%1.02%1.17%0.97%1.08%

According to 12 Wall Street analysts, UnitedHealth Group's projected average Quarter EPS for Dec 23 is $5.98, with a low estimate of $5.90 and a high estimate of $6.02. This represents a -5.16% decrease compared to UNH previous annual EPS of $6.31 (Sep 23).

UnitedHealth Group Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ELVElevance Health$400.30$525.3331.23%Buy
CNCCentene$63.91$81.5027.52%Buy
CVSCVS Health$56.90$71.3325.36%Buy
UNHUnitedHealth Group$538.10$625.0016.15%Buy
MOHMolina Healthcare$304.28$345.5013.55%Hold
CICigna$303.31$318.745.09%Buy
HUMHumana$294.23$276.71-5.95%Hold
ALHCAlignment Healthcare$15.32$9.00-41.25%Buy

UNH Forecast FAQ

Is UnitedHealth Group a good buy?

Yes, according to 32 Wall Street analysts, UnitedHealth Group (UNH) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 26 'Buy' recommendations, accounting for 84.38% of UNH's total ratings.

What is UNH's price target?

UnitedHealth Group (UNH) average price target is $625 with a range of $595 to $650, implying a 16.15% from its last price of $538.1. The data is based on 32 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will UnitedHealth Group stock go up soon?

According to Wall Street analysts' prediction for UNH stock, the company can go up by 16.15% (from the last price of $538.1 to the average price target of $625), up by 20.80% based on the highest stock price target, and up by 10.57% based on the lowest stock price target.

Can UnitedHealth Group stock reach $800?

UNH's average twelve months analyst stock price target of $625 does not support the claim that UnitedHealth Group can reach $800 in the near future.

What are UnitedHealth Group's analysts' financial forecasts?

UnitedHealth Group's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $485.82B (high $493.99B, low $473.63B), average EBITDA is $46.02B (high $46.8B, low $44.87B), average net income is $31.02B (high $31.7B, low $30.01B), average SG&A $14.44B (high $14.68B, low $14.08B), and average EPS is $33.47 (high $34.2, low $32.37). UNH's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $512.4B (high $521.02B, low $499.54B), average EBITDA is $48.54B (high $49.36B, low $47.32B), average net income is $34.37B (high $35.12B, low $33.25B), average SG&A $15.23B (high $15.49B, low $14.85B), and average EPS is $37.08 (high $37.89, low $35.87).

Did the UNH's actual financial results beat the analysts' financial forecasts?

Based on UnitedHealth Group's last annual report (Dec 2022), the company's revenue was $322.13B, beating the average analysts forecast of $321.41B by 0.22%. Apple's EBITDA was $29.8B, beating the average prediction of $28.49B by 4.62%. The company's net income was $20.12B, beating the average estimation of $19.11B by 5.31%. Apple's SG&A was $0, missing the average forecast of $38.52B by -100.00%. Lastly, the company's EPS was $21.47, beating the average prediction of $21.18 by 1.37%. In terms of the last quarterly report (Sep 2023), UnitedHealth Group's revenue was $92.36B, beating the average analysts' forecast of $91.41B by 1.04%. The company's EBITDA was $9.53B, beating the average prediction of $8.66B by 10.08%. UnitedHealth Group's net income was $5.84B, missing the average estimation of $5.87B by -0.52%. The company's SG&A was $0, missing the average forecast of $2.72B by -100.00%. Lastly, the company's EPS was $6.31, missing the average prediction of $6.33 by -0.38%